TAZ shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Tolfenamic acid negatively regulates YAP and TAZ expression in human cancer cellsBiochimica et biophysica acta. Molecular cell researchDecember 1, 2023Kim I, Lertpatipanpong P, Yoon Y, Lee J, Hong Y, Boonruang K, Ryu J, Baek SJ.

(2) Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancerThe FEBS journalMarch 1, 2023Seo E, Jee B, Chung JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, et al.

(3) YWHAE-NUTM2 oncoprotein regulates proliferation and cyclin D1 via RAF/MAPK and Hippo pathwaysOncogenesisMay 4, 2021Ou WB, Lundberg MZ, Zhu S, Bahri N, Kyriazoglou A, Xu L, Chen T, Mariño-Enriquez A, Fletcher JA.

(4) Ligation of HLA Class I Molecules Induces YAP Activation through Src in Human Endothelial CellsJournal of immunology (Baltimore, Md. : 1950)October 1, 2020Anwar T, Sinnett-Smith J, Jin YP, Reed EF, Rozengurt E.

(5) Transforming growth factor beta induces fibroblasts to express and release the immunomodulatory protein PD-L1 into extracellular vesiclesFASEB journal : official publication of the Federation of American Societies for Experimental BiologyFebruary 1, 2020Kang JH, Jung MY, Choudhury M, Leof EB.

(6) Rac-GTPase promotes fibrotic TGF-β1 signaling and chronic kidney disease via EGFR, p53, and Hippo/YAP/TAZ pathwaysFASEB journal : official publication of the Federation of American Societies for Experimental BiologySeptember 1, 2019Patel S, Tang J, Overstreet JM, Anorga S, Lian F, Arnouk A, Goldschmeding R, Higgins PJ, Samarakoon R.

(8) Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo PathwayCancer cellDecember 10, 2018Li Z, Razavi P, Li Q, Toy W, Liu B, Ping C, Hsieh W, Sanchez-Vega F, Brown DN, Da Cruz Paula AF, et al.

(12) YAP regulates cell mechanics by controlling focal adhesion assemblyNature communicationsMay 15, 2017Nardone G, Oliver-De La Cruz J, Vrbsky J, Martini C, Pribyl J, Skládal P, Pešl M, Caluori G, Pagliari S, Martino F, et al.

(13) Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer ProgressionClinical cancer research : an official journal of the American Association for Cancer ResearchOctober 1, 2015Lee J, Condello S, Yakubov B, Emerson R, Caperell-Grant A, Hitomi K, Xie J, Matei D.

(16) Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cellsExperimental & molecular medicineDecember 12, 2014Hwang SM, Jin M, Shin YH, Ki Choi S, Namkoong E, Kim M, Park MY, Park K.

(17) Hypoxic conditions differentially regulate TAZ and YAP in cancer cellsArchives of biochemistry and biophysicsNovember 15, 2014Yan L, Cai Q, Xu Y.

(18) Opioid receptor blockade and warmth-liking: effects on interpersonal trust and frontal asymmetrySocial cognitive and affective neuroscienceOctober 1, 2014Schweiger D, Stemmler G, Burgdorf C, Wacker J.

(19) Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructureACS nanoMarch 25, 2014Mosqueira D, Pagliari S, Uto K, Ebara M, Romanazzo S, Escobedo-Lucea C, Nakanishi J, Taniguchi A, Franzese O, Di Nardo P, et al.

(20) Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanomaThe Journal of investigative dermatologyJanuary 1, 2014Nallet-Staub F, Marsaud V, Li L, Gilbert C, Dodier S, Bataille V, Sudol M, Herlyn M, Mauviel A.

TAZ shRNA Plasmid (h)